Publication|Articles|September 19, 2025
- Pharmaceutical Executive: September 2025
- Volume 45
- Issue 7
Pharmaceutical Executive: September 2025 Interactive Digital Edition
View the Pharmaceutical Executive September 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
11 months ago
Can AI Point the Way?12 months ago
Turning AI Pilots into Enterprise Value12 months ago
Paul Hudson: A Mindset for Miracles12 months ago
How AI is Shaping KOL and DOL Identification12 months ago
What Innovation in PBM Management Really Looks Like12 months ago
Measuring the ROI of SPP Adherence ProgramsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5